Brief: Nanexa Signs Evaluation Agreement With Global Pharmaceutical Company
29/11/2023 08:10
Nov 29 (Reuters) - Nanexa AB NANEXA.ST :
* SIGNS EVALUATION AGREEMENT WITH A MAJOR GLOBAL
PHARMACEUTICAL
COMPANY
* HAS SIGNED MATERIAL TRANSFER AND FEASIBILITY STUDY
AGREEMENT
WITH MAJOR PHARMACEUTICAL CO FOR THE EVALUATION OF NANEXA'S DRUG
DELIVERY SYSTEM PHARMASHELL
* AGREEMENT REGULATES DETAILS OF WHAT IS TO BE INVESTIGATED,
CLARIFICATION OF PATENT RIGHTS AND A FIXED FEE TO NANEXA FOR
THIS EVALUATION
Source text for Eikon: ID:nMFN1GkNH5
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))